Plus TherapeuticsCNSY
13F holders, Q4 2025 (December 31)27holders +4
10new positions
6sold out
1famous investor
$0.51avg. 13F price*
At the end of Q4 2025, 27 institutions reported holding Plus Therapeutics Inc. (CNSY) in their 13F filings, up 4 from Q3 2025. 10 opened new positions and 6 sold out. The largest holders were Vanguard Group Inc. ($1.2M), L1 Global Manager Pty Ltd ($1.2M) and BlackRock, Inc. ($910K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Plus Therapeutics Inc.
- CUSIP
- 72941H509
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $1.1M |
| Exits | 6 | $796K |
All 13F filers, Q3 2025 → Q4 2025: 5,239,166 shares bought and 1,166,327 shares sold, net +4,072,839 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| Vanguard Group Inc. | 0.00% | Add +57.5% | 2,279,414 | $1.2M |
| L1 Global Manager Pty Ltd | 0.76% | — | 2,277,703 | $1.2M |
| BlackRock, Inc. | 0.00% | Add +278.4% | 1,776,372 | $910K |
| Geode Capital Management, LLC | 0.00% | Add +72.5% | 1,402,794 | $719K |
| Jane Street Group, LLC | 0.00% | New | 1,023,905 | $525K |
| UBS Group AG | 0.00% | Add +40.4% | 875,846 | $448K |
| Virtu Financial LLC | 0.01% | New | 496,762 | $254K |
| State Street Corp. | 0.00% | Add +37.1% | 468,893 | $240K |
| Northern Trust Corp. | 0.00% | Add +10.5% | 293,300 | $150K |
| XTX Topco Ltd | 0.00% | New | 248,560 | $127K |
| Citadel Advisors | 0.00% | New | 185,056 | $95K |
| Two Sigma Securities, LLC | 0.00% | Add +404.4% | 55,883 | $29K |
| Citigroup Inc. | 0.00% | New | 48,456 | $25K |
| Dagco, Inc. | 0.00% | No change | 25,882 | $13K |
| Kestra Advisory Services, LLC | 0.00% | No change | 25,800 | $13K |
| Ashton Thomas Private Wealth, LLC | 0.00% | New | 24,913 | $13K |
| HighTower Advisors, LLC | 0.00% | New | 16,000 | $8K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | Add +28.1% | 13,450 | $7K |
| J.W. Cole Advisors, Inc. | 0.00% | New | 10,000 | $5K |
| Royal Bank of Canada | 0.00% | New | 1,400 | $1K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -44.9% | 1,843 | $944 |
| Bank of America Corp. | 0.00% | Add +52.2% | 1,265 | $648 |
| Osaic Holdings, Inc. | 0.00% | No change | 133 | $67 |
| Wells Fargo & Company | 0.00% | No change | 53 | $27 |
| Sound Income Strategies, LLC | 0.00% | New | 28 | $8 |
| Barclays PLC | 0.00% | No change | 2 | $1 |
| Danske Bank A/S | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is CNSY's weight in each manager's 13F, not the share of Plus Therapeutics Inc. the manager owns.